Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Accumulated Expenses (2022 - 2025)

Historic Accumulated Expenses for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to $1.8 million.

  • InflaRx's Accumulated Expenses rose 178576.53% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 178576.53%. This contributed to the annual value of $2.2 million for FY2024, which is 2902.22% up from last year.
  • Latest data reveals that InflaRx reported Accumulated Expenses of $1.8 million as of Q3 2025, which was up 178576.53% from -$1.1 million recorded in Q2 2025.
  • In the past 5 years, InflaRx's Accumulated Expenses ranged from a high of $2.2 million in Q4 2024 and a low of -$1.4 million during Q1 2025
  • Moreover, its 4-year median value for Accumulated Expenses was -$448390.7 (2023), whereas its average is -$109575.1.
  • As far as peak fluctuations go, InflaRx's Accumulated Expenses surged by 275156.65% in 2023, and later plummeted by 25745.69% in 2024.
  • InflaRx's Accumulated Expenses (Quarter) stood at -$65320.3 in 2022, then skyrocketed by 2751.57% to $1.7 million in 2023, then grew by 27.38% to $2.2 million in 2024, then fell by 20.04% to $1.8 million in 2025.
  • Its Accumulated Expenses was $1.8 million in Q3 2025, compared to -$1.1 million in Q2 2025 and -$1.4 million in Q1 2025.